Drug Trial Radar · NCT02614196
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
Last checked: Nov 20, 2026Latest source record: Jun 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
986
Actual
Start
Dec 4, 2015
Primary completion
Mar 29, 2017
Study completion Oct 5, 2018
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 25, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy and safety of the study drug known as galcanezumab in participants with episodic migraine.
Conditions
- Migraine
Interventions
GalcanezumabDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Mean Change From Baseline in the Number of Monthly Migraine Headache DaysTime frame: Baseline, Month 1 through Month 6
Locations
113 sites in 12 countries. Site status is shown where the registry gives one.
21st Century Neurology
Phoenix, Arizona
Arizona Research Center
Phoenix, Arizona
Axiom Research
Apple Valley, California
Cedars Sinai Medical Center
Los Angeles, California
Catalina Research Institute, LLC
Montclair, California
Pacific Research Partners, LLC
Oakland, California
Medical Center for Clinical Research
San Diego, California
Optimus Medical Group
San Francisco, California
Schuster Medical Research Institute
Sherman Oaks, California
IMMUNOe International Research Centers
Centennial, Colorado
Clinical Research of South Florida
Coral Gables, Florida
Sunrise Clinical Research
Hollywood, Florida
Westside Center for Clinical Research
Jacksonville, Florida
Clinical Neuroscience Solutions Inc
Jacksonville, Florida
Sensible Healthcare
Ocoee, Florida
Meridien Research
Tampa, Florida
Atlanta Center of Medical Research
Atlanta, Georgia
Christie Clinic, LLC
Champaign, Illinois
Diamond Headache Clinic
Chicago, Illinois
Josephson Wallack Munshower Neurology
Indianapolis, Indiana
Heartland Research Associates
Wichita, Kansas
Novex Clinical Research
New Bedford, Massachusetts
QUEST Research Institute
Farmington Hills, Michigan
Healthcare Research Network - Hazelwood
Hazelwood, Missouri
Nevada Headache Institute
Las Vegas, Nevada
Bio Behavioral Health
Toms River, New Jersey
Albuquerque Clinical Trials
Albuquerque, New Mexico
Regional Clinical Research
Binghamton, New York
SPRI Clinical Trials, LLC.
Brooklyn, New York
High Point Clinical Trials Center
High Point, North Carolina
Neurology & Neuroscience Associates, Inc.
Akron, Ohio
Univ of Cincinnati College of Medicine
Cincinnati, Ohio
Urgent Care Specialists, LLC
Columbus, Ohio
Urgent Care Specialists, LLC
Dayton, Ohio
IPS Research Company
Oklahoma City, Oklahoma
Oregon Neurology Associates
Springfield, Oregon
Clinical Research of Philadelphia
Philadelphia, Pennsylvania
Mountain View Clinical Research, Inc
Greer, South Carolina
Coastal Carolina Research Center, Inc.
Mt. Pleasant, South Carolina
FutureSearch Trials
Dallas, Texas
Showing 40 of 113 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.